Evidence map›Paper›PMID 32836185›Full record

ArticleSleep medicine2020

Sleep problems among Chinese adolescents and young adults during the coronavirus-2019 pandemic.

Shuang-Jiang Zhou, Lei-Lei Wang, Rui Yang, Xing-Jie Yang, Li-Gang Zhang, Zhao-Chang Guo, Jin-Cheng Chen, Jing-Qi Wang, Jing-Xu Chen

Open access · greenAbstract read
In one paragraph

Article in Sleep medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 158 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
158citing papers in PubMed, 9 pooled it
44.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

158 citing papers in PubMed, 9 syntheses or guidelines pooled it, 322 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

98 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Shuang-Jiang ZhouBeijing HuiLongGuan Hospital, Peking University HuiLongGuan Clinical Medical School, Beijing, China.
Lei-Lei WangBeijing HuiLongGuan Hospital, Peking University HuiLongGuan Clinical Medical School, Beijing, China.
Rui YangBeijing Anding Hospital, Capital Medical University, Beijing, China.
Xing-Jie YangBeijing HuiLongGuan Hospital, Peking University HuiLongGuan Clinical Medical School, Beijing, China.
Li-Gang ZhangBeijing HuiLongGuan Hospital, Peking University HuiLongGuan Clinical Medical School, Beijing, China.
Zhao-Chang GuoThe First High School of Juxian, Rizhao, Shandong Province, China.
Jin-Cheng ChenThe Experimental Middle School of Chengde, Hebei Province, China.
Jing-Qi WangBinhai Eco-city School-Tianjin Nankai High School, Tianjin, China.
Jing-Xu ChenBeijing HuiLongGuan Hospital, Peking University HuiLongGuan Clinical Medical School, Beijing, China. Electronic address: chenjx1110@163.com.
Peking University · CNCapital Medical University · CNCenter for High Pressure Science & Technology Advanced Research · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the prevalence and sociodemographic correlates of insomnia symptoms among Chinese adolescents and young adults affected by the outbreak of coronavirus disease-2019 (COVID-19).

methodsThis cross-sectional study included Chinese adolescents and young adults 12-29 years of age during part of the COVID-19 epidemic period. An online survey was used to collect demographic data, and to assess recognition of COVID-19, insomnia, depression, and anxiety symptoms using the Pittsburgh Sleep Quality Index (PSQI), the Patient Health Questionnaire (PHQ-9), and the Generalized Anxiety Disorder (GAD-7) questionnaires, respectively. The Social Support Rate Scale was used to assess social support.

resultsAmong 11,835 adolescents and young adults included in the study, the prevalence of insomnia symptoms during part of the COVID-19 epidemic period was 23.2%. Binomial logistic regression analysis revealed that female sex and residing in the city were greater risk factors for insomnia symptoms. Depression or anxiety were risk factors for insomnia symptoms; however, social support, both subjective and objective, was protective factors against insomnia symptoms. Furthermore, anxiety and depression symptoms were mediators of social support and insomnia symptoms.

conclusionsResults of this study revealed a high prevalence of sleep problems among adolescents and young adults during the COVID-19 epidemic, especially senior high school and college students, which were negatively associated with students' projections of trends in COVID-19. The adverse impact of COVID-19 was a risk factor for insomnia symptoms; as such, the government must devote more attention to sleep disorders in this patient population while combating COVID-19.

Indexed as

BetacoronavirusPandemicsAdolescentAdultAnxietyChildChinaCoronavirus InfectionsCOVID-19Cross-Sectional StudiesDepressionFemaleHumansMalePneumonia, ViralSARS-CoV-2AdolescentsCOVID-19InsomniaPrevalenceYoung adults

Identifiers

PMID32836185
PMCPMC7274988
OpenAlexW3033214140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.